We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biomarkers Prove Role of Food for Diabetics

By LabMedica International staff writers
Posted on 27 Sep 2017
Diet is frequently associated with both the development and prevention of type 2 diabetes (T2D), but there is a lack of objective tools for assessing the relation between diet and T2D.

A pioneering method has demonstrated its potential in a large study, showing that metabolic fingerprints from blood samples could render important new knowledge on the connection between food and health and that diet is one of the strongest predictors of type 2 diabetes risk in older women.

Scientists at the Chalmers University of Technology (Gothenburg, Sweden) measured dietary biomarkers were measured in plasma from 64-y-old Swedish women with different glucose tolerance status (GTS). More...
There were 190 with normal glucose tolerance (NGT), 209 with impaired glucose tolerance (IGT), and 230 diagnosed with diabetes. The same subjects were followed up after five years to determine changes in glucose tolerance (167 for NGT, 174 for IGT, and 159 for diabetes).

The blood samples were analyzed, using gas chromatography-tandem mass spectrometry metabolomics where a unique metabolic fingerprint, including many different diet biomarkers, could be linked to each woman at the specific time the sample was taken. Samples were injected onto a Shimadzu GCMS TQ-8030 GC-MS/MS and both scan and multiple reaction monitoring data was collected for further data analysis. Using this method it was possible for the first time to objectively determine the impact of key dietary components on future type 2 diabetes risks, as well as to find differences in dietary patterns between women with and without type 2 diabetes.

The team reported that of the 10 dietary biomarkers analyzed, β-alanine (beef), alkylresorcinols C17 and C19 (whole-grain wheat and rye), eicosapentaenoic acid (fish), 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) (fish), linoleic acid, oleic acid and α-tocopherol (margarine and vegetable oil) were associated with GTS. CMPF and α-tocopherol were inversely associated with future T2D development.

Alastair B. Ross, PhD, an associate professor and lead author of the study, said, “The new method has allowed us to measure several markers of diet and nutrient status at the same time in a large number of people, which we believe is the first time this has been done. New methods such as ours will help to improve how we measure diet and understand in more detail how dietary patterns relate to disease.” The study was published on September 13, 2017, in the American Journal of Clinical Nutrition.

Related Links:
Chalmers University of Technology


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.